| Key features | - BTC and ETH futures automation on Coinbase Derivatives Exchange
- Paper trading with configurable simulated funds
- Shadow simulation with account-based starting balance
- Observation mode for account monitoring from a second device
- Detailed backtesting with one-second bid and ask data
- Local API-key encryption on device
- Coinbase-hosted stop-loss and take-profit orders
- Market condition visibility and entry requirements display
- Estimated contract capacity and fund requirements
- Guided Demo for learning without trading
| - 30-second stock analysis with DNA score from 0-100
- Analysis across 2,000+ signals spanning fundamentals, valuation, technicals, momentum, sentiment, and risk
- Ten composite category scores including Business Quality, Growth Outlook, Financial Strength, Valuation, Institutional, Trend & Structure, Momentum, Relative Strength, Risk, and News Sentiment
- Plain-English breakdowns of quantitative analysis
- Side-by-side stock comparison with dual DNA radars
- Stock screener with pre-built theme baskets including Penny Stocks, Growth Stocks, Value Stocks, Dividend Income, Quality Blue-Chips, Momentum Breakouts, Oversold Bounces, and High Risk/High Reward
- Watchlist that tracks DNA score changes for each stock
- Daily score updates recalculated each evening after market close
- Free financial calculators including Buffett Score, Intrinsic Value, DCF Calculator, PEG Calculator, Compound Interest, and Retirement Projector
- Access to 5,200+ analyzed US stocks
|
|---|
| What makes it different | - On-device execution with credentials encrypted locally, never sent to Citrine Edge
- Built-in strategy without requiring users to write code or assemble trading rules
- Unified workspace evaluating BTC and ETH markets together with shared allocation
- Explore free with simulations and backtesting before purchasing Complete subscription
- Margin-aware fund and contract capacity estimates with current account context
| - Converts 2,000+ data points into one instantly understandable 0-100 DNA score instead of hours of spreadsheet research
- Fixed, published formula methodology rather than subjective analyst opinions
- Scores recalculated daily with real-time quote updates rather than static quarterly snapshots
- Presents scores as objective data-driven labels rather than buy/sell recommendations
- Analyzes institutional ownership, sentiment, and technicals alongside fundamentals in one composite view
|
|---|
Citrine™
StockDNA